No Data
Aerovate Therapeutics Stockholders Approve Proposed Merger With Jade Biosciences; Board Approves 1-for-35 Reverse Stock Split
Express News | Aerovate Therapeutics Inc - Board Approves 1-for-35 Reverse Stock Split
Aerovate Therapeutics Stockholders Approve Proposed Merger With Jade Biosciences And All Related Proposals >AVTE
Aerovate Therapeutics Declares Special Cash Dividend Of $69.6M, Or An Estimated $2.40 Per Share
Aerovate Therapeutics: Cash Div Expected to Be in the Range of $67.6M-$69.6M >AVTE
Express News | Aerovate Therapeutics Announces Range of Expected Cash Dividend in Connection With the Proposed Merger With Jade Biosciences